COVID-19 Vaccine Market: By Vaccine Type, By Technology and Geograpy

download arrow download arrow Download Free Sample
settings arrow settings arrow email us

COVID-19 Vaccine Market Size, Share, Growth, Trends, and Global Industry Analysis: By Vaccine Type (Inactivated Virus, Protein Subunit, Non-replicating Viral Vector, Repurposed Vaccines, RNA Vaccine, DNA Vaccine, Genetic Vaccine), By Technology (Vector-based, Nucleic acid-based, Protein-based, Whole Virus) and Geograpy

checked icon arrow_drop_down
checked icon Single User License $4400 $3520
checked icon Multiple User License $6600 $5280
checked icon Corporate User License $8900 $7120

COVID-19 vaccine market size is valued at US$ billion in 2021 and is expected to reach a value of US$ billion by 2028, expected to grow at a significant CAGR from 2022 to 2028. The global market provides a detailed overview and which can be segmented by vaccine type and technology. The COVID-19 vaccine market has been segmented by vaccine type into Inactivated Virus, Protein Subunit, Non-replicating Viral Vector, Repurposed Vaccines, RNA Vaccine, DNA Vaccine, and Genetic Vaccine. The RNA Vaccine segment is likely the largest and fastest-growing in terms of vaccine types. Based on technology, the COVID-19 vaccine is segmented into Vector-based, Nucleic acid-based, Protein-based, and Whole Viruses. According to precision business insights, the Vector-based segment is predicted to register the fastest growth rate during the forecast period.

Covid 19 Vaccine Market Key Development:
  • In October 2021, Pfizer received the US FDA Emergency Use Authorization (EUA) for the Pfizer-BioNTech COVID-19 Vaccine for children 5 through 11 years of age.
  • In August 2021, Pfizer-BioNTech COVID-19 vaccine COMIRNATY received full US FDA approval for individuals 16 years and older.

summary download arrow Download Free Sample

Covid 19 Vaccine Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

x%

Largest Market

North America

Fastest Growing Market

Asia-Pacific

COVID-19 Vaccine Market Dynamics

With greater healthcare awareness, the focus on immunization has shifted significantly, and various government agencies are working to achieve this goal. For example, Immunise Australia is an Australian government program that helps people buy immunizations.

Covid 19 Vaccine Market Segmentation Analysis

Report Benchmarks

Details

Report Study Period

2024-2030

Market CAGR

x%

Vaccine Type

  • Inactivated Virus,
  • Protein Subunit,
  • Non-replicating Viral Vector,
  • Repurposed Vaccines,
  • RNA Vaccine,
  • DNA Vaccine,
  • Genetic Vaccine

By Technology

  • Vector-based,
  • Nucleic acid-based,
  • Protein-based,
  • Whole Virus

By Region

  • North America,
  • Europe,
  • Asia Pacific,
  • Latin America, and
  • Middle East and Africa

Key Features of the Report

  • The COVID-19 vaccine market report provides granular level information about the market size, regional market share, historic market (2017-2021), and forecast (2022-2028)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario

Download Free Sample Report

I accept the Terms and Conditions,Disclaimers, GDPR Policy

Frequently Asked Questions

The COVID-19 vaccine market is projected to expand at a CAGR of x% during the forecast period.

The major global COVID-19 vaccine market players are ??? AstraZeneca, GlaxoSmithKline, Moderna, Gamaleya, Bharat Biotech, Pfizer, Johnson & Johnson, BioNTech, CureVac, Serum Institute of India, Novavax, Sinovac, and Sinopharm.

Asia Pacific is the fastest-growing region for COVID-19 vaccine arket

Author image

Author

Muni Kumar Meravath

Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....

1. Executive Summary
2. Global COVID-19 Vaccine Market Introduction
2.1. Global COVID-19 Vaccine Market Taxonomy
2.2. Global COVID-19 Vaccine Market Definitions
2.2.1. By Vaccine Type
2.2.2. By Technology
2.2.3. By Region
3. Global COVID-19 Vaccine Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global COVID-19 Vaccine Market Dynamic Factors - Impact Analysis
3.6. Global COVID-19 Vaccine Market Competition Landscape
4. Global COVID-19 Vaccine Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030
4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Opportunity Analysis
5. Global COVID-19 Vaccine Market, By Vaccine Type, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) 
5.1. Inactivated Virus
5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3. Market Opportunity Analysis
5.2. Protein Subunit
5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis
5.3. Non-replicating Viral Vector
5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.3. Market Opportunity Analysis
5.4. Repurposed Vaccines
5.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.4.3. Market Opportunity Analysis
5.5. RNA Vaccine
5.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
5.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.5.3. Market Opportunity Analysis
5.6. DNA Vaccine
5.6.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
5.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.6.3. Market Opportunity Analysis
5.7. Genetic Vaccine
5.7.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
5.7.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.7.3. Market Opportunity Analysis
6. Global COVID-19 Vaccine Market, By Technology, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) 
6.1. Vector-based
6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Nucleic acid-based
6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
6.3. Protein-based
6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.3.3. Market Opportunity Analysis
6.4. Whole Virus
6.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.4.3. Market Opportunity Analysis
7. Global COVID-19 Vaccine Market Forecast, By Region, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) 
7.1. North America
7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Europe
7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
7.3. Asia-Pacific
7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.3.3. Market Opportunity Analysis
7.4. Latin America
7.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.4.3. Market Opportunity Analysis
7.5. Middle East and Africa
7.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.5.3. Market Opportunity Analysis
7.6. Global COVID-19 Vaccine Market - Opportunity Analysis Index, By Vaccine Type, Technology, and Region, 2024 - 2030
8. North America COVID-19 Vaccine Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) 
8.1. Vaccine Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
8.1.1. Inactivated Virus
8.1.2. Protein Subunit
8.1.3. Non-replicating Viral Vector
8.1.4. Repurposed Vaccines
8.1.5. RNA Vaccine
8.1.6. DNA Vaccine
8.1.7. Genetic Vaccine
8.2. Technology Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
8.2.1. Vector-based
8.2.2. Nucleic acid-based
8.2.3. Protein-based
8.2.4. Whole Virus
8.3. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
8.3.1. USA
8.3.2. Canada
8.4. North America COVID-19 Vaccine Market - Opportunity Analysis Index, By Vaccine Type, Technology, and Country, 2024 - 2030
8.5. North America COVID-19 Vaccine Market Dynamics Trends
9. Europe COVID-19 Vaccine Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) 
9.1. Vaccine Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
9.1.1. Inactivated Virus
9.1.2. Protein Subunit
9.1.3. Non-replicating Viral Vector
9.1.4. Repurposed Vaccines
9.1.5. RNA Vaccine
9.1.6. DNA Vaccine
9.1.7. Genetic Vaccine
9.2. Technology Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
9.2.1. Vector-based
9.2.2. Nucleic acid-based
9.2.3. Protein-based
9.2.4. Whole Virus
9.3. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
9.3.1. Germany
9.3.2. UK
9.3.3. France
9.3.4. Spain
9.3.5. Italy
9.3.6. Russia
9.3.7. Rest of Europe
9.4. Europe COVID-19 Vaccine Market - Opportunity Analysis Index, By Vaccine Type, Technology, and Country, 2024 - 2030
9.5. Europe COVID-19 Vaccine Market Dynamics Trends
10. Asia-Pacific COVID-19 Vaccine Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) 
10.1. Vaccine Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.1.1. Inactivated Virus
10.1.2. Protein Subunit
10.1.3. Non-replicating Viral Vector
10.1.4. Repurposed Vaccines
10.1.5. RNA Vaccine
10.1.6. DNA Vaccine
10.1.7. Genetic Vaccine
10.2. Technology Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.2.1. Vector-based
10.2.2. Nucleic acid-based
10.2.3. Protein-based
10.2.4. Whole Virus
10.3. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
10.3.1. China
10.3.2. India
10.3.3. Japan
10.3.4. ASEAN
10.3.5. Australia & New Zealand
10.3.6. Rest of Asia-Pacific
10.4. Asia-Pacific COVID-19 Vaccine Market - Opportunity Analysis Index, By Vaccine Type, Technology, and Country, 2024 - 2030
10.5. Asia-Pacific COVID-19 Vaccine Market Dynamics Trends
11. Latin America COVID-19 Vaccine Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) 
11.1. Vaccine Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.1.1. Inactivated Virus
11.1.2. Protein Subunit
11.1.3. Non-replicating Viral Vector
11.1.4. Repurposed Vaccines
11.1.5. RNA Vaccine
11.1.6. DNA Vaccine
11.1.7. Genetic Vaccine
11.2. Technology Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.2.1. Vector-based
11.2.2. Nucleic acid-based
11.2.3. Protein-based
11.2.4. Whole Virus
11.3. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
11.3.1. Brazil
11.3.2. Mexico
11.3.3. Argentina
11.3.4. Rest of Latin America
11.4. Latin America COVID-19 Vaccine Market - Opportunity Analysis Index, By Vaccine Type, Technology, and Country, 2024 - 2030
11.5. Latin America COVID-19 Vaccine Market Dynamics Trends
12. Middle East and Africa COVID-19 Vaccine Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) 
12.1. Vaccine Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.1.1. Inactivated Virus
12.1.2. Protein Subunit
12.1.3. Non-replicating Viral Vector
12.1.4. Repurposed Vaccines
12.1.5. RNA Vaccine
12.1.6. DNA Vaccine
12.1.7. Genetic Vaccine
12.2. Technology Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.2.1. Vector-based
12.2.2. Nucleic acid-based
12.2.3. Protein-based
12.2.4. Whole Virus
12.3. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
12.3.1. Gulf Cooperation Council (GCC) Countries
12.3.2. Israel
12.3.3. South Africa
12.3.4. Rest of MEA
12.4. MEA COVID-19 Vaccine Market - Opportunity Analysis Index, By Vaccine Type, Technology, and Country, 2024 - 2030
12.5. MEA COVID-19 Vaccine Market Dynamics Trends
13. Competition Landscape 
13.1. Strategic Dashboard of Top Market Players
13.2. Company Profiles (Introduction, Financial Analysis, Vaccine Type Offerings, Key Developments, Strategies, and SWOT Analysis)
13.2.1. AstraZeneca
13.2.2. GlaxoSmithKline
13.2.3. Moderna
13.2.4. Gamaleya
13.2.5. Bharat Biotech
13.2.6. Pfizer
13.2.7. Johnson & Johnson
13.2.8. BioNTech
13.2.9. CureVac
13.2.10. Serum Institute of India
13.2.11. Novavax
13.2.12. Sinovac
13.2.13. Sinopharm
14. Research Methodology
15. Key Assumptions and Acronyms

Key Market Players

  • AstraZeneca
  • GlaxoSmithKline
  • Moderna
  • Gamaleya
  • Bharat Biotech
  • Pfizer
  • Johnson & Johnson
  • BioNTech
  • CureVac
  • Serum Institute of India
  • Novavax
  • Sinovac
  • Sinopharm

Related Industry Reports

Chronic Refractory Gout Pharmaceuticals Market

Familial Mediterranean Fever Pharmaceuticals Market

Australia Point of Care Diagnostics Market

Aseptic Sampling Market